Hitomi Usui

1.9k total citations · 1 hit paper
14 papers, 1.6k citations indexed

About

Hitomi Usui is a scholar working on Nephrology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Hitomi Usui has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Clinical Biochemistry and 3 papers in Molecular Biology. Recurrent topics in Hitomi Usui's work include Chronic Kidney Disease and Diabetes (8 papers), Advanced Glycation End Products research (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Hitomi Usui is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Advanced Glycation End Products research (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Hitomi Usui collaborates with scholars based in Japan, United States and Australia. Hitomi Usui's co-authors include Hirofumi Makino, Kenichi Shikata, Jun Wada, Kumar Sharma, Yanqing Zhu, Daisuke Ogawa, Yasushi Shikata, Shinichi Okada, Mitsuhiro Matsuda and Ryo Nagase and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Diabetes.

In The Last Decade

Hitomi Usui

14 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiponectin regulates albuminuria and podocyte function in mice

2008 498 citations Kumar Sharma, Satish RamachandraRao et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hitomi Usui Japan	13	659	444	369	297	293	14	1.6k
Elyce Ozols Australia	13	744 1.1×	534 1.2×	256 0.7×	213 0.7×	392 1.3×	23	1.7k
Daisuke Ogawa Japan	22	605 0.9×	793 1.8×	816 2.2×	245 0.8×	259 0.9×	51	2.2k
Maria Lajer Denmark	24	431 0.7×	462 1.0×	466 1.3×	269 0.9×	138 0.5×	53	1.7k
Koji Kuboki Japan	10	275 0.4×	505 1.1×	440 1.2×	181 0.6×	287 1.0×	22	1.5k
Usha Panchapakesan Australia	22	585 0.9×	593 1.3×	681 1.8×	126 0.4×	321 1.1×	32	1.8k
Satish RamachandraRao United States	12	493 0.7×	417 0.9×	200 0.5×	275 0.9×	94 0.3×	14	1.3k
Akira Mima Japan	26	524 0.8×	542 1.2×	641 1.7×	143 0.5×	147 0.5×	66	1.6k
Tamotsu Yokota Japan	21	338 0.5×	589 1.3×	315 0.9×	127 0.4×	149 0.5×	37	1.4k
Yachun Han China	25	549 0.8×	1.0k 2.4×	213 0.6×	402 1.4×	270 0.9×	58	2.1k
Keiichiro Matoba Japan	18	385 0.6×	480 1.1×	337 0.9×	154 0.5×	154 0.5×	41	1.2k

Countries citing papers authored by Hitomi Usui

Since Specialization

Citations

This map shows the geographic impact of Hitomi Usui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Usui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Usui more than expected).

Fields of papers citing papers by Hitomi Usui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Usui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Usui. The network helps show where Hitomi Usui may publish in the future.

Co-authorship network of co-authors of Hitomi Usui

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Usui. A scholar is included among the top collaborators of Hitomi Usui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Usui. Hitomi Usui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kodera, Ryo, Kenichi Shikata, Satoshi Miyamoto, et al.. (2013). Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes. Biochemical and Biophysical Research Communications. 443(3). 828–833. 84 indexed citations

Sharma, Kumar, Satish RamachandraRao, Gang Qiu, et al.. (2008). Adiponectin regulates albuminuria and podocyte function in mice. Journal of Clinical Investigation. 118(5). 1645–56. 498 indexed citations breakdown →

Zhu, Yanqing, Hitomi Usui, & Kumar Sharma. (2007). Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment. Seminars in Nephrology. 27(2). 153–160. 74 indexed citations

Usui, Hitomi, Kenichi Shikata, Motofumi Sasaki, et al.. (2007). Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation. Diabetes. 56(2). 363–372. 77 indexed citations

Tone, Atsuhito, Kenichi Shikata, Daisuke Ogawa, et al.. (2007). Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor. Journal of the Renin-Angiotensin-Aldosterone System. 8(1). 45–50. 22 indexed citations

Shikata, Kenichi, Kosuke Yozai, Shinichi Okada, et al.. (2006). Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation. American Journal of Physiology-Renal Physiology. 292(4). F1141–F1150. 174 indexed citations

Yozai, Kosuke, Kenichi Shikata, Motofumi Sasaki, et al.. (2005). Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions. Journal of the American Society of Nephrology. 16(11). 3326–3338. 74 indexed citations

Horiuchi, Seikoh, Yuka Unno, Hitomi Usui, et al.. (2005). Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36. Annals of the New York Academy of Sciences. 1043(1). 671–675. 32 indexed citations

Tone, Atsuhito, Kenichi Shikata, Mitsuhiro Matsuda, et al.. (2005). Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 69(3). 237–242. 108 indexed citations

10.

Tone, Atsuhito, Kenichi Shikata, Motofumi Sasaki, et al.. (2005). Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia. 48(11). 2402–2411. 35 indexed citations

11.

Ogawa, Daisuke, Kenichi Shikata, Koichi Honke, et al.. (2004). Cerebroside Sulfotransferase Deficiency Ameliorates L-selectin-dependent Monocyte Infiltration in the Kidney after Ureteral Obstruction. Journal of Biological Chemistry. 279(3). 2085–2090. 33 indexed citations

12.

Usui, Hitomi. (2003). HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrology Dialysis Transplantation. 18(2). 265–272. 119 indexed citations

13.

Okada, Shinichi, Kenichi Shikata, Mitsuhiro Matsuda, et al.. (2003). Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes. Diabetes. 52(10). 2586–2593. 260 indexed citations

14.

Sugimoto, Taro, Yasushi Yamasaki, Mizuho Kobayashi, et al.. (2002). [A case of minimal change nephrotic syndrome manifesting acute renal failure in the course of systemic lupus erythematosus].. PubMed. 44(5). 476–82. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact